Dassault Systèmes (DSY) Q1 2026 Investor Call earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 Investor Call earnings summary
23 Apr, 2026Executive summary
Q1 2026 revenue grew 3% year-over-year at constant currency, meeting objectives and supported by execution on strategic priorities.
Recurring software revenue comprised 85% of total software revenue, with ARR up 6% year-over-year to €4.37 billion.
Operating cash flow increased 22% to €949 million, reflecting strong business model and earnings quality.
Mainstream Innovation, led by SOLIDWORKS and CENTRIC, delivered strong growth, while Life Sciences faced headwinds.
Full-year 2026 objectives and guidance confirmed, with focus on AI, operational efficiency, and scaling industrial AI offerings.
Financial highlights
Total Q1 revenue reached €1.51 billion, up 3% year-over-year at constant currency.
Mainstream Innovation software revenue grew 14% year-over-year, while Industrial Innovation was flat and Life Sciences declined 3%.
Operating margin (non-IFRS) was 30.3%, with EPS up 4% to €0.30 (non-IFRS).
Operating cash flow was €949 million, up 22% year-over-year; free cash flow rose 27%.
Americas software revenue down 1%, Europe up 7%, Asia up 3% year-over-year.
Outlook and guidance
Full-year 2026 non-IFRS revenue guidance: €6.29–€6.41 billion, 3–5% growth in constant currencies.
Operating margin expected at 32.2–32.6%, EPS of €1.30–€1.34 (3–6% growth in constant currencies).
Q2 2026 non-IFRS revenue guidance: €1.518–€1.568 billion, up 2–5% in constant currencies.
H2 2026 expected to improve over H1, with positive run rate growth entering 2027.
Tax rate expected at ~17.8% for FY26; currency assumptions: $1.18/€ and JPY 173.37/€.
Latest events from Dassault Systèmes
- Q1 2026 saw 3% revenue growth, strong cash flow, and confirmed outlook with robust AI and cloud momentum.DSY
Q1 202623 Apr 2026 - Pascal Daloz succeeds Bernard Charlès, driving continuity in Industrial AI and 3D UNIV+RSES.DSY
Investor update23 Feb 2026 - FY25 revenue up 4% to €6,240M, strong recurring/cloud growth; FY26 targets 3–5% growth.DSY
Q4 2025 Investor Call11 Feb 2026 - FY26 targets 3–5% revenue growth, margin expansion, and strong ARR momentum.DSY
Q4 202511 Feb 2026 - Revenue and EPS rose, with robust cloud and 3DEXPERIENCE growth; outlook remains strong.DSY
Q2 20249 Feb 2026 - Q2 revenue up 6%, guidance reaffirmed, strong 3DEXPERIENCE and cloud growth.DSY
Q2 20259 Feb 2026 - Q3 saw 5% revenue growth, margin expansion, and strong recurring revenue momentum.DSY
Q3 20253 Feb 2026 - 5% revenue growth, 30.1% margin, and strong subscription momentum despite Life Sciences headwinds.DSY
Q3 2025 Investor Call3 Feb 2026 - Revenue and EPS guidance lowered for 2024, but H2 outlook and strategic focus remain strong.DSY
Guidance3 Feb 2026